Endomyocardial biopsy (EMB) is central to the diagnosis of giant-cell myocarditis (GCM) and planning further management. There is, however, no guideline-directed recommendation on re-biopsy or left ventricular EMB in a suspected case of acute, fulminant myocarditis following an indeterminate first biopsy. This manuscript illustrates, with a case, the changing role for EMB in the current era in the diagnosis of GCM.
- Endomyocardial biopsy (EMB)
- Giant cell
- Left ventricular EMB
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine